What Every Hospital CIO Should Know Before Choosing a Genomics Platform

Genomics is no longer a “pilot project.” It has become infrastructure.

As precision medicine programs mature, hospital CIOs are being asked to evaluate, and often purchase, platforms that support sequencing, interpretation, and reporting at clinical scale.

But genomics is not just another dataset. It is a moving target of complexity, regulation, and clinical nuance. Choosing the wrong platform does not just slow things down. It can lock teams into workflows that do not scale.

If your hospital is building its genomics foundation, here is what to look for.

1. What clinical grade reporting should a hospital genomics platform deliver?

Short answer: Hospital CIOs should prioritize platforms that produce clinician ready genomic reports out of the box. That means structured, templated outputs for PGx, oncology, and inherited risk that are version controlled, auditable, and easy to integrate with EHR and LIS systems.

A platform that cannot deliver clinician ready outputs is not a platform. It is an experiment.

Genomic platforms must support:

  • Structured, templated reports tailored to PGx, oncology, and inherited risk
  • Interpretive logic that is version controlled and auditable
  • Outputs that are compatible with EHR and LIS systems

Without clinical usability, your investment becomes academic.

2. How should hospital CIOs evaluate security and governance in genomics platforms?

Short answer: Genomic data carries clinical, research, and IRB overlays, so platforms must support role based access, detailed audit logs, and de identification workflows. The vendor should meet HIPAA expectations, support BAAs, and have real experience in high security hospital environments.

Genomic data is sensitive and comes with research, IRB, and compliance overlays that most platforms were not built for.

Look for features like:

  • Role based access and audit logs
  • Honest Broker and de identification workflows
  • HIPAA compliant deployment and a signed BAA
  • Support for your health system’s internal security review and risk frameworks

Make sure the vendor has actual experience operating in high security environments, not only a claim that they can.

3. Why are dry lab bottlenecks a hidden risk in clinical genomics?

Short answer: Many programs invest in wet lab capacity but leave interpretation and reporting as manual work. If the dry lab is not automated, turnaround times slip, headcount grows, and clinicians lose confidence in genomic results.

Wet lab throughput is usually the first thing to be optimized. The real bottleneck appears later, when variants need to be interpreted, templated, and turned into clinician ready reports.

If your platform does not streamline these dry lab steps, you will need more analysts just to keep up with sample volume. Queues grow, turnaround time stretches, costs rapidly increase and inconsistencies in interpretation undercut provider trust.

Scalable platforms automate as much of the analysis, templating, and reporting workflow as possible. They reduce manual effort, protect turnaround time, and increase report quality at the same time.

4. Why do one off scripts and custom pipelines fail at hospital scale?

Short answer: One off research pipelines are hard to govern, validate, and maintain. Enterprise hospitals need genomics platforms with transparent, versioned pipelines and configurable logic so they can add new panels and indications without rebuilding everything.

Custom pipelines can be fine for a small research group. Enterprise health systems are different. They need repeatable, documented workflows that can pass clinical, legal, and security review.

Look for:

  • Pipeline logic that is visible and versioned
  • Annotation rules that are configurable, not hard coded
  • Modular support for new panels, assays, and indications

If every change requires a new script or a fragile rebuild, your team will slow down and risk inconsistent results. A scalable platform lets your genomics program grow without constantly reinventing the infrastructure.

How PraediGene supports CIO level needs for clinical genomics

Short answer: PraediGene is a clinical grade genomics platform designed for hospitals. It provides end to end analysis, templated reporting, robust security and IRB support, and structured outputs for integration, proven inside large integrated health systems.

PraediGene is a clinical grade genomics platform designed for hospitals, not only research labs. It delivers:

  • Full secondary and tertiary analysis pipelines
  • Templated, decision ready reporting for multiple use cases
  • Built in support for secure access, auditability, and IRB protocols
  • Structured outputs ready for EHR integration
  • A track record of performance inside the largest integrated health system in the U.S.

It is not just a reporting tool. It is a scalable, enterprise ready solution for hospitals that are moving from genomics strategy to clinical delivery.

Frequently Asked Questions by CIOs

Hospital CIOs should prioritize platforms that produce clinician ready genomic reports out of the box. That means structured, templated outputs for PGx, oncology, and inherited risk that are version controlled, auditable, and easy to integrate with EHR and LIS systems.

Genomic data carries clinical, research, and IRB overlays, so platforms must support role based access, detailed audit logs, and de identification workflows. The vendor should meet HIPAA expectations, support BAAs, and have real experience operating in high security hospital environments.

Many programs invest in wet lab capacity but leave interpretation and reporting as manual work. If the dry lab is not automated, turnaround times slip, headcount grows, costs rapidly increase, and clinicians lose confidence in genomic results.

One off research pipelines are hard to govern, validate, and maintain. Enterprise hospitals need genomics platforms with transparent, versioned pipelines and configurable logic so they can add new panels and indications without rebuilding everything.

PraediGene is a clinical grade genomics platform designed for hospitals. It provides end to end analysis, templated reporting, robust security and IRB support, and structured outputs for EHR integration, proven inside large integrated health systems.

If you’re a hospital CIO, PraediGene is ready when you are.

Whether you are building a business case, scoping an RFP, or shortlisting vendors, PraediGene can map your requirements to a real deployment plan. Bring your questions on reporting, security, dry lab workflows, and pipelines. We will show you exactly how we address each one.

CONTACT US TO GET A CIO FOCUSED WALKTHROUGH